Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-01-04 @ 8:55 AM
Study NCT ID:
NCT02272803
Status:
COMPLETED
Last Update Posted:
2022-06-22
First Post:
2014-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-21
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-21
First Submit QC Date:
None
Study First Post Date:
2014-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-26
Results First Submit QC Date:
None
Results First Post Date:
2018-03-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-27
Last Update Post Date:
2022-06-22
Last Update Post Date Type:
ACTUAL